Related Experiment Videos
Gene therapy as a potential treatment for restenosis and myocardial infarction
N Tomita1, R Morishita, Y Kaneda
1Department of General Medicine, Osaka University Hospital, Suita, Japan.
Insights
Gene therapy, using decoy oligonucleotides (ODN) and efficient gene transfer, offers a promising new approach to treat cardiovascular diseases like restenosis and myocardial infarction by targeting underlying causes.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Gene Therapy
Background:
- Cardiovascular diseases are a leading cause of death and illness, with conventional treatments often addressing symptoms rather than root causes.
- Gene therapy presents a novel strategy to address the pathogenetic processes underlying cardiovascular disorders.
- Advances in molecular biology have significantly improved gene transfer technologies.
Purpose of the Study:
- To review the potential of gene therapy for cardiovascular disease prevention and treatment.
- To highlight the efficacy of decoy oligonucleotide (ODN) strategies in antigene therapy.
- To discuss the successful application of decoy ODN combined with gene transfer for treating cardiovascular conditions.
Main Methods:
- Utilizing gene transfer into somatic cells to modulate disease processes.
- Employing cis element double-stranded oligonucleotides (decoy ODN) as an antigene strategy.
- Reviewing studies that combine decoy ODN with efficient gene transfer methods.
Main Results:
- Decoy ODN strategies have emerged as a powerful tool in gene therapy.
- Successful treatment of restenosis and myocardial infarction has been demonstrated.
- Efficient gene transfer methods enhance the therapeutic potential of decoy ODN.
Conclusions:
- Gene therapy, particularly using decoy ODN, offers a novel and effective approach for cardiovascular disease treatment.
- Targeting underlying pathogenetic mechanisms provides a more comprehensive treatment strategy.
- The combination of decoy ODN and efficient gene transfer holds significant promise for cardiovascular medicine.
Abstract:
Cardiovascular disease is the leading cause of mortality and morbidity in developed countries. Most conventional therapy is inefficient and tends to treat the symptoms rather than the underlying causes of the disorder. Gene therapy offers a novel approach for the prevention and treatment of cardiovascular diseases. Gene transfer into somatic cells to interfere with the pathogenetic processes contributing to cardiovascular disease may provide such a novel approach for better prevention and treatment of cardiovascular disorders. The major development of gene transfer has importantly contributed to intense investigation of the potential of gene therapy in cardiovascular medicine. The amazing advances in molecular biology have provided a dramatic improvement in the technology that is necessary to transfer target genes into somatic cells. Recently, transfection of cis element double-stranded oligonucleotides (ODN), referred to as decoy ODN, has been reported to be a powerful tool in a new class of antigene strategies for gene therapy. In this article, we review the successful treatment of restenosis and myocardial infarction using the decoy strategy combined with an efficient gene transfer method.